Clinical Trials Open for Enrollment

Below are immunotherapy trials currently enrolling patients with ovarian, cervical or uterine / endometrial cancers. Click on "Am I eligible for this trial?" for a list of the basic requirements for enrollment. If you believe the patient is eligible and interested in a clinical trial, please email the study contact who will request medical records and complete a preliminary screening and can explain the next steps.

Cancer Type	Protocol Title	ClinicalTrials.Gov Link	Eligibility Criteria	Study Contact
Ovarian	Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers	Humanized CAR-T-mesothelin	Am I eligible for this trial?	Carebox
Ovarian (CAR-T)	MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	MOv19-BBz	Am I eligible for this trial?	Tina Matlawski
Ovarian (CAR-T)	A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer	TC 210	Am I eligible for this trial?	Katie Elkins
Ovarian	Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination with VCN-01 in Patients With Pancreatic and Serous Epithelial Ovarian Cancer	huCART	Am I eligible for this trial?	Carebox
Ovarian	A Phase 1 Study of SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR, in Subjects with Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma	STAR	Am I eligible for this trial?	Katie Elkins
Cervical	A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer	Xencor	Am I eligible for this trial?	Isabel Forbes